Advanced search
Publication Cover
Microcirculation Volume 9, 2002 - Issue 1
Submit an article Journal homepage
2
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Use of Antisense Oligonucleotides: Advantages, Controls, and Cardiovascular Tissue

TERESA GOLDEN Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL
,
NICHOLAS M. DEAN Department of Pharmacology, ISIS Pharmaceuticals, Carlsbad, CA, USA
&
RICHARD E. HONKANEN Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, ALCorrespondence[email protected]
Pages 51-64 | Published online: 27 Nov 2010

  • Agrawal S. (1999). Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim Biophys Acta 1489:53*#x2013;68.
  • Agrawal S, Temsamani J, Galbraith W, Tang J. (1995). Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 28:7*#x2013;16.
  • Agrawal S, Temsamani J, Tang JY. (1991). Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci USA 88:7595*#x2013;7599.
  • Akhtar S, Kole R, Juliano RL. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 49:1793*#x2013;1801.
  • Altmann KH, Dean NM, Fabbro D, Freier SM, Geiger T, Haner R, Husken D, Martin P, Monia BP, Muller M, Natt F, Nicklin P, Phillips J, Pieles U, Sasmor H, Moser HE. (1996). Second-generation of antisense Use of antisense oligonucleotides Golden et al. 61 oligonucleotides: from nuclease resistance to biological efficacy in animals. Chimia 50:168*#x2013;176.
  • Altmann KH, Fabbro D, Dean NM, Geiger T, Monia BP, Muller M, Nicklin P. (1996). Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors. Biochem Soc Tansact 24:630*#x2013;637.
  • An H, Wang T, Maier MA, Manoharan M, Ross BS, Cook PD. (2001). Synthesis of novel 38-C-methylene thymidine and 5-methyluridine/cytidine Hphosphonates and phosphonamidites for new backbone modification of oligonucleotides. J Org Chem 66:2789*#x2013;2801.
  • Anderson KP, Fox MC, Brown-Driver V, Martin MJ, Azad RF. (1996). Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob Agents Chemother 40:2004*#x2013;2011.
  • Arino J, Woon CW, Brautigan DL, Miller TB Jr, Johnson GL. (1988). Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. Proc Natl Acad Sci USA 85:4252*#x2013;4256.
  • Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF. (1997). 28-O- (2-methoxy)ethyl-modified anti-intracellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272:11994*#x2013;12000.
  • Barker HM, Brewis ND, Street AJ, Spurr, NK, Cohen, PT. (1994). Three genes for protein phosphatase 1 map to different human chromosomes: sequence, expression and gene localisation of protein serine/ threonine phosphatase 1 beta (PPP1CB). Biochem Biophys Acta 1220:212*#x2013;218.
  • Bastians H, Ponstingl H. (1996). The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. J Cell Sci 109:2865*#x2013;2874.
  • Becker W, Kentrup H, Klumpp S, Schultz JE, Joost HG. (1994). Molecular cloning of protein serine/ threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. J Biol Chem 269:22586*#x2013;22592.
  • Bennett CF, Chiang MY, Chan H, Shoemaker JEE, Mirabelli CK. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41:1023*#x2013;1033.
  • Buchardt O, Egholm M, Berg RH, Neilsen PE. (1993). Peptide nucleic acids (PNA) and their potential applications in medicine and biotechnology. Trends Biotechnol 11:384*#x2013;386.
  • Campbell JM, Bacon TA, Wickstrom E. (1990). Oligodeoxynucleoside phosphorothiolate stablilty in subcellular extracts, culture media, sera, and cerebrospinal fluid. J Biochem Biophys Methods 20:259*#x2013;267.
  • Cheng A, Dean NM, Honkanen RE. (2000). Serine/ threonine protein phosphatase type 1g1 is required for the completion of cytokinesis in human A549 lung carcinoma cells. J Biol Chem 275:1846*#x2013;1854.
  • Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF. (1991). Antisense oligonucleotides inhibit intracellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem 266:18162*#x2013;18171.
  • Cohen PTW. (1997). Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 22:245*#x2013;251.
  • Cooper SR, Taylor JK, Miraglia LJ, Dean NM. (1999). Pharmacology of antisense oligonucleotide inhibitors of protein expression. Pharmacol Ther 82: 427*#x2013;435.
  • Cossum PA, Sasmor H, Dellinger D, Truong L, Cummins L, Owens SR, Markham PM, Shea JP, Crooke S. (1993). Disposition of the 14C-labeled phophorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J Pharmocol Exp Ther 267:1181*#x2013;1190.
  • Culman J. (2000). Antisense oligonucleotides in the study of central mechanisms of the cardiovascular regulation. Exp Physiol 85:757*#x2013;767.
  • Dagle JM, Andracki ME, DeVine RJ, Walder JA. (1991). Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages. Nucleic Acids Res 19:1805*#x2013;1810.
  • Dean NM, Cooper SR, Shanahan W, Taylor J, Myers K. (2000). Pharmacology of antisense oligonucleotides. J Clin Ligand Assay 23:43*#x2013;49.
  • Dean NM, Griffey RH. (1997). Identification and characterization of second-generation antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 7:229*#x2013;233.
  • Dean NM, McKay R. (1994). Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 91:11762*#x2013;11766.
  • Dean NM, McKay R, Condon TP, Bennett CF. (1994). Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intracellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269:16416*#x2013;16424.
  • DeMesmaeker A, Altmann KH, Waldner A, Wendeborn S. (1995). Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr Opin Struct Biol 5:343*#x2013;355.
  • Disney MD, Testa SM, Turner DH. (2000). Targeting a Pneumocystis carinii group I intron with methylphosphonate oligonucleotides: backbone charge is not required for binding or reactivity. Biochemistry 39:6991*#x2013;7000.
  • Dominski Z, Kole R. (1993). Restoration of correct Use of antisense oligonucleotides Golden et al. 62 splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc Natl Acad Sci USA 90:8673*#x2013;8677.
  • Fisher SA, Langille BL, Srivastava D. (2000). Apoptosis during cardiovascular development. Circ Res 87:856*#x2013;864.
  • Galbraith WM, Hobson WC, Giclas PC, Schechter PJ, Agrawal S. (1994). Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res Dev 4:201*#x2013;206.
  • Geary RS, Watanabe TA, Truong L, Freier S, Lesnik EA, Sioufi NB, Sasmor H, Manoharan M, Levin AA. (2001). Pharmacokinetic properties of 28-O-(2- Methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmocol Exp Ther 296:890*#x2013;897.
  • Gryaznov SM. (1999). Oligonucleotide N38-P58 phosphoramidates as potential therapeutic agents. Biochim Biophys Acta 1489:131*#x2013;140.
  • Guvakova MA, Yakubov LA, Vlodavsky I, Tonkinson JL, Stein CA. (1995). Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 270:2620*#x2013;2627.
  • Henry SP, Novotny W, Leeds J, Auletta C, Kornbrust DJ. (1997). Inhibition of coagulation by a phosphorothioate oligonucleotide. Antisense Nucleic Acid Drug Dev 7:503*#x2013;510.
  • Hodges D, Crooke ST. (1995). Inhibition of splicing of wild-type and mutated luciferase adenovirus premRNAs by antisense oligonucleotides. Mol Pharmacol 48:905*#x2013;918.
  • Hreniuk D, Garay M, Gaarde W, Monia BP, McKay RA, Cioffi CL. (2001). Inhibition of C-Jun NTerminal Kinase1, but not c-Jun N-terminal Kinase 2, suppresses apoptosis induced by ischemia/ reoxygenation in rat cardiac myocytes. Mol Pharmacol 59:867*#x2013;874.
  • Hudziak RM, Summerton J, Weller DD, Iversen PL. (2000). Antiproliferative effects of steric blocking phophoroiamidate morpholino antisense agents directed against c-myc. Antisense Nucleic Acid Drug Dev 10:163*#x2013;176.
  • Huang X, Cheng A, Honkanen RE. (1997). Genomic organization of the human PP4 gene encoding a serine/ threonine protein phosphatase (PP4) suggests a common ancestry with PP2A. Genomics 44:336*#x2013;343.
  • Inoue H, Hayase Y, Iwai S, Ohtsuke E. (1987). Sequence dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett 215:327*#x2013;330.
  • Kakinuma Y, Miyauchi T, Yuki K, Murakoshi N, Goto K, Yamaguchi I. (2001). Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1a induced for impaired myocardial energy metabolism. Circulation 103:2387*#x2013;2394.
  • Kang SH, Cho MJ, Kole R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37:6235.
  • Kawasaki AM, Casper MD, Freier SM, Lesnik EA, Zounes MC, Cummins LL, Gonzalez C, Cook PD. (1993). Uniformly modified 28-deoxy-28-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem 36:831*#x2013;841.
  • Kishioka H, Fukuda N, Nakayama M, Hu WY, Satoh C, Kanmatsuse K, Manoharan M. (2000). Effect of methylene methylimino linkage of antisense oligonucleotide to the platelet-derived growth factor Achain on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Eur J Pharmacol 392:129*#x2013;132.
  • Krieg AM. (1999). Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta 1489:107*#x2013;116.
  • Larson HJ, Bentin T, Nielsen PE. (1999). Antisense properties of peptide nucleic acid. Biochim Biophys Acta 1489:159*#x2013;166.
  • Levin A. (1999). A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim Biophys Acta 1489:69*#x2013;84.
  • Manoharan M, Tivel KL, Andrade LK. (1995). Oligonucleotide conjugates: alteration of the pharmacokinetic properties of antisense agents. Nucleosides Nucleotides 14:969*#x2013;973.
  • Marcusson EG, Bhat B, Manoharan M, Bennett CF, Dean NM. (1998). Phosphorothioate oligodeoxynucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res 26:2016*#x2013;2023.
  • Marcusson EG, Yacyshyn BR, Shanahan WR, Dean NM. (1999). Preclinical and clinical pharmacology of antisense oligonucleotides. Mol Biotechol 12:1*#x2013;11.
  • McKay RA, Cummins LL, Graham MJ, Lesnik EA, Owens SR, Winniman M, Dean NM. (1996). Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 28-O-propyl modifications. Nucleic Acids Res 24:411*#x2013;417.
  • McKay RA, Miraglia L, Cummins L, Owens S, Sasmor H, Dean NM. (1999). Characterization of a potent and specific class of antisense oligonucleotide inhibitor of protein kinase C-alpha expression. J Biol Chem 274:1715*#x2013;1722.
  • Meyers KJ, Dean NM. (2000). Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol Sci 21:19*#x2013;23.
  • Michiels C, Arnould T, Remacle J. (2000). Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 1497:1*#x2013;10.
  • Miller PS, Cassidy RA, Hamma T, Kondo NS. (2000). Studies on anti-human immunodeficiency virus oli- Use of antisense oligonucleotides Golden et al. 63 gonucleotides that have alternating methylphosphonate/ phosphodiester linkages. Pharmacol Ther 85:159*#x2013;163.
  • Monia B, Johnston JF, Sasmor H, Cummins LL. (1996). Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J Biol Chem 24:14533*#x2013;14540.
  • Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, Guinosso CJ, Kawasaki AM, Cook PD, Freier SM. (1993). Evaluation of 28 modified oligonucleotides containing deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514*#x2013;14522.
  • Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF, Crooke ST. (1997). Immune stimulation*#x2013;a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des 12:421*#x2013;432.
  • Nicklin PL, Bayley D, Giddings J, Craig SJ, Cummins LL, Hastewell JG, Phillips JA. (1998). Pulmonary bioavailability of a phosphorothioate oligonucleotide (CGP 64128A): comparison with other delivery routes. Pharm Res 15:583*#x2013;591.
  • Perez JR, Li Y, Stein CA, Majumder S, Van Oorschot A, Narayanan R. (1994). Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 91:5957*#x2013;5961.
  • Reed JC. (1999). Splicing and dicing apoptosis genes. Nat Biotechnol 17:1064*#x2013;1065.
  • Reynolds MA, Hogrefe RI, Jaeger JA, Schwartz DA, Riley TA, Marvin WB, Daily WJ, Vaghefi MM, Beck TA, Knowles SK, Klem RE, Arnold LJ. (1996). Synthesis and thermodynamics of oligonucleotides containing chirally pure R(P) methylphosphonate linkages. Nucleic Acids Res 24:4584*#x2013;4591.
  • Sands H, Gorey-Feret LJ, Cocuzza AJ, Hobbs FW, Chidester D, Trainor GL. (1994). Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 45:932*#x2013;943.
  • Semenza G. (2000). Hypoxia, clonal selection, and the role of HIF1 in tumor progression. Crit Rev Biochem Mol Biol 35:71*#x2013;103.
  • Shaw BR, Sergueev D, He K, Porter K, Summers J, Sergueeva Z, Rait V. (2000). Boranophosphate backbone: a mimic of phosphodiesters, phosphorothioates, and methyl phosphonates. Methods Enzymol 313:226*#x2013;257.
  • Shibahara S, Mukai S, Nishihara T, Inoue H, Ohtsuka E, Morisawa H. (1987) Site-directed cleavage of RNA. Nucleic Acids Res 15:4403*#x2013;4415.
  • Sierakowska H, Sambade MJ, Agrawal S, Kole R. (1996). Repair of thalassemic human b-globin mRNA in mammalian cells by antisense oligonucleotides. Proc Natl Acad Sci USA 93:12840*#x2013;12844.
  • Song Q, Khanna KK, Lu H, Lavin MF. (1993). Cloning and characterization of a human protein phosphatase 1-encoding cDNA. Gene 129:291*#x2013;295.
  • Stone SR, Hofsteenge J, Hemmings BA. (1987). Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. Biochemistry 26:7215*#x2013;7220.
  • Summerton J. (1999). Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta 1489:141*#x2013;158.
  • Suzuki T, Miyauchi T. (2001). A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes. Am J Physiol Regul Integrat Comp Physiol 280:R1399*#x2013;R1406.
  • Taylor JK, Dean NM. (1999). Regulation of premRNA splicing by antisense oligonucleotides. Curr Opin Drug Discov Dev 2:147*#x2013;151.
  • Taylor JK, Zhang QQ, Wyatt JR, Dean NM. (1999). Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat Biotechnol 17:1097*#x2013;1100.
  • Thierry AR, Dritschilo A. (1992). Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxnucleotides for antisense activity. Nucleic Acids Res 20:5691*#x2013;5698.
  • Traub O, Monia BP, Dean NM, Berk BC. (1997). PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endotheilial cells. J Biol Chem 272:31251*#x2013;31257.
  • Tsukamoto Y, Matsuo N, Ozawa K, Hori O, Higashi T, Nishizaki J, Tohnai N, Nagata I, Kawano K, Yutani C, Hirota S, Kitamura Y, Stern DM, Ogawa S. (2001). Expression of a novel RNA-splicing factor, RA301/Tra2b, in vascular lesions and its role in smooth muscle cell proliferation. Am J Pathol 158:1685*#x2013;1694.
  • Vickers TA, Wyatt JR, Burckin T, Bennett CF, Freier SM. (2001). Fully modified 28 MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res 29:1293*#x2013;1299.
  • Wyatt JR, Davis PW, Freier SM. (1996). Kinetics of G-quartet-mediated tetramer formation. Biochemistry 35:8002*#x2013;8008.
  • Yakubov L, Khaled Z, Zhang LM, Truneh A, Vlassov, Stein CA. (1993). Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J Biol Chem 268:18818*#x2013;18823.
  • Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. (1992). Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 148:4072*#x2013;4076.
  • Zamecnik PC, Stephenson ML. (1978). Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75:289*#x2013;294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.